ILDS COVID-19 Guidance

The ILDS has issued the following guidance notes:

• Guidance on the Practice of Dermatosurgery and Cosmetic Procedures During the Covid-19 (Sars-Cov-2, Coronavirus) Pandemic (June 2020)
• Guidance on the Use of Immunomodulatory and Immunosuppressive Drugs in Dermatology in the Era of COVID-19 (March 2021)
• Guidance on the Use of Systemic Therapy for Patients with Psoriasis/Atopic Dermatitis During the Covid-19 (Sars-Cov-2, Coronavirus) Pandemic (March 2021)